Aarti Drugs Limited


Intraday Data as updated on 27-May-2020 13:08:50
OpenHighLowClose
8888908630
Historical Data Points
52W High52W High Date52W Low52W Low Date
89027-May-202042123-Mar-2020
PE Ratios
InustryIndexSector PEStock PE
PHARMACEUTICALSNIFTY PHARMA 29.3415.18
Capital Structure
Issued Capital23,300,000
Face Value10.00
Paid Value10.00
Free Float Market Capital7,002,651,900
DateDetailDescriptionFile
19-May-2020 21:33ClarificationAARTIDRUGS: The Exchange has sought clarification from Aarti Drugs Limited with respect to announcement dated 16-May-2020, regarding Appointment of Shri Narendra Jagannath Salvi as Non-Executive Director of the Company . On basis of above the Company is required to clarify following: 1. Date of appointment/cessation (as applicable) & term of appointmentThe response of the Company is awaited.Link
18-May-2020 19:02Press ReleaseAarti Drugs Limited has informed the Exchange regarding a press release dated May 18, 2020, titled "Press Release for March 2020".Link
16-May-2020 13:35UpdatesAarti Drugs Limited has informed the Exchange regarding 'Outcome of the Board Meeting Appointment of Director'.Link
15-May-2020 19:06Analysts/Institutional Investor Meet/Con. Call UpdatesAarti Drugs Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call UpdatesLink
15-May-2020 14:38Financial Result UpdatesAarti Drugs Limited has submitted to the Exchange, the financial results for the period ended March 31, 2020.Link
16-Apr-2020 11:02Disclosure under SEBI Takeover RegulationsPromoter of Aarti Drugs Limited has informed the Exchange regarding Disclosures under Regulation 30 of SEBI SAST RegulationsLink
13-Apr-2020 19:38UpdatesAarti Drugs Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018'.Link
13-Apr-2020 16:59Price movementSignificant movement in price has been observed in Aarti Drugs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Aarti Drugs Limited has submitted their response.Link
09-Apr-2020 20:06Price movementSignificant movement in price has been observed in Aarti Drugs Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.Link
30-Mar-2020 18:43Trading WindowAarti Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015Link
07-Feb-2020 14:33Press ReleaseAarti Drugs Limited has informed the Exchange regarding a press release dated February 07, 2020, titled "Press release for December 19".Link
06-Feb-2020 16:29Record DateAarti Drugs Limited has informed the Exchange that the Company has fixed Record Date as February 18, 2020 for the purpose of payment of Interim Dividend.Link
06-Feb-2020 16:14DividendAarti Drugs Limited has informed the Exchange that Board of Directors at its meeting held on February 06, 2020, declared Interim Dividend of 2 per equity share.Link
06-Feb-2020 16:03Financial Result UpdatesAarti Drugs Limited has submitted to the Exchange, the financial results for the period ended December 31, 2019.Link
05-Feb-2020 15:00Analysts/Institutional Investor Meet/Con. Call UpdatesAarti Drugs Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call UpdatesLink
04-Feb-2020 20:00UpdatesAarti Drugs Limited has informed the Exchange regarding 'Intimation of Loss of share certificates'.Link
07-Jan-2020 12:47UpdatesAarti Drugs Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018'.Link
06-Jan-2020 14:53AcquisitionThis is to inform you that Company has incorporated a Wholly Owned Subsidiary (WOS) Company namely Pinnacle Life Science LLC registered with International Free Zone Authority, Fujairah at United Arab Emirates (U.A.E.) on January 5, 2020.Link
31-Dec-2019 12:28Trading WindowAarti Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015Link
24-Dec-2019 14:50Analysts/Institutional Investor Meet/Con. Call UpdatesAarti Drugs Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call UpdatesLink
19-Dec-2019 08:42UpdatesAarti Drugs Limited has informed the Exchange regarding 'Regulation 30(6) of SEBI ( L ODR) Regulation 2015'.Link
21-Nov-2019 18:07Disclosure under SEBI Takeover RegulationsSeema Harshit Savla has submitted to the Exchange, vide letter dated November 21, 2019 a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.Link
21-Nov-2019 10:48AcquisitionThis is to inform you that Company has incorporated a Wholly Owned Subsidiary (WOS) Company namely Aarti Speciality Chemicals Limited CIN No: U24230MH2019PLC333306 on November 20, 2019.Link
20-Nov-2019 10:00UpdatesAarti Drugs Limited has informed the Exchange regarding 'Compliance under Regulation 23(9) of SEBI (LODR) Regulations, 2015'.Link
07-Nov-2019 19:53Disclosure under SEBI Takeover RegulationsSeema Harshit Savla has submitted to the Exchange vide letter dated November 07, 2019 a copy of Disclosure as per Regulation 10(5) of SEBI (SAST) Regulation 2011Link
31-Oct-2019 16:41AcquisitionAarti Drugs Limited has informed the Exchange about Incorporation of marketing subsidiary namely Pinnacle Chile SpA in Chile.Link
24-Oct-2019 13:01Press ReleaseAarti Drugs Limited has informed the Exchange regarding a press release dated October 24, 2019, titled "Press release for September 19".Link
23-Oct-2019 19:09Analysts/Institutional Investor Meet/Con. Call UpdatesAarti Drugs Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call UpdatesLink
23-Oct-2019 17:29Financial Result UpdatesAarti Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2019.Link
14-Oct-2019 15:25UpdatesAarti Drugs Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.'.Link
30-Sep-2019 13:35Trading WindowAarti Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015Link
08-Aug-2019 11:53Shareholders meetingAarti Drugs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 06, 2019. Further, the company has informed the Exchange regarding voting results.Link
07-Aug-2019 11:52Shareholders meetingAarti Drugs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 06, 2019Link
07-Aug-2019 11:34UpdatesAarti Drugs Limited has informed the Exchange regarding 'Proceeding of 34th Annual General Meeting'.Link
29-Jul-2019 13:32Press ReleaseAarti Drugs Limited has informed the Exchange regarding a press release dated July 29, 2019, titled "Press release for Juneᅡメ19".Link
26-Jul-2019 17:30Analysts/Institutional Investor Meet/Con. Call UpdatesAarti Drugs Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call UpdatesLink
26-Jul-2019 16:58Credit RatingAarti Drugs Limited has informed the Exchange regarding Credit RatingLink
26-Jul-2019 15:16Financial Result UpdatesAarti Drugs Limited has submitted to the Exchange, the financial results for the period ended June 30, 2019.Link
17-Jul-2019 19:07UpdatesAarti Drugs Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018'.Link
12-Jul-2019 11:23Book ClosureAarti Drugs Limited has informed the Exchange that the Company has fixed Book Closure from July 30, 2019 to August 6, 2019 for the purpose of AGM and payment of dividendLink
28-Jun-2019 21:34Trading WindowAarti Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015Link
14-Jun-2019 09:04Related Party TransactionsAarti Drugs Limited has submitted to the Exchange a copy disclosure of Related Party Transactions on a' con basis for the half vear ended March 31, 2019.Link
14-Jun-2019 09:04Related Party TransactionsAarti Drugs Limited has submitted to the Exchange a copy disclosure of Related Party Transactions on a' con basis for the half vear ended March 31, 2019.Link
30-May-2019 17:56Post Buyback Public AnnouncementInga Advisors pvt Ltd has informed the Exchange regarding Post Buyback public Announcement for the attention of equity shareholder/beneficial owners of Equity shares of the Company.Link
29-May-2019 17:02Investor PresentationAarti Drugs Limited has informed the Exchange regarding Investor PresentationLink

Source: Click here to subscribe data via APIs

Welcome Back!

Login to your account below

Create New Account!

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.